STABILE HYALURONAN-/STEROID-FORMULIERUNG

Patent europeic · EP3622820 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3622820
Numer da la dumonda
EP19186507
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
10-08-2010
Publitgà
18-03-2020
Concedì
18-02-2026
La protecziun finescha il pli tard
09-08-2030
Proxima taxa annuala scadenta
31-08-2026
Classas IPC
A61K 31/58 (2006.01)
A61P 29/00 (2006.01)
A61K 9/00 (2006.01)
A61P 19/02 (2006.01)
A61K 47/36 (2006.01)
A61K 31/728 (2006.01)
Prioritad
US 55686909 10.09.2009
Derivà da
EP10815804
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 18-02-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 18.02.2026

Partidas

Possessur

Genzyme Corporation

50 Binney Street, Cambridge, MA 02142, US

Inventur

CHANG, Grace

Brookline, Massachusetts 02446, US

VOSCHIN, Elizabeth

Needham, Massachusetts 02494, US

YU, Li-Ping

Ashland, Massachusetts 01721, US

SKRABUT, Eugene

Rockport, Massachusetts 01966, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.